BDBM434021 1-(4-(1H-pyrazol-4- yl)phenyl)-4-benzyl- 3-(1-hydroxyethyl)- 1H-1,2,4-triazol- 5(4H)-one (nantiomer 1)::US10562887, Example 140::US10562887, Example 141

SMILES CC(O)c1nn(-c2ccc(cc2)-c2cn[nH]c2)c(=O)n1Cc1ccccc1

InChI Key InChIKey=IZPMEHUSYBMCQR-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 434021   

TargetRho-associated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM434021(US10562887, Example 141 | 1-(4-(1H-pyrazol-4- yl)p...)
Affinity DataIC50: 27.5nMAssay Description:The effectiveness of compounds of the present invention as ROCK inhibitors can be determined in a 30 μL, assay containing 20 mM HEPES, pH 7.5, 2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
US Patent

TargetRho-associated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM434021(US10562887, Example 141 | 1-(4-(1H-pyrazol-4- yl)p...)
Affinity DataIC50: 27.5nMAssay Description:The effectiveness of compounds of the present invention as ROCK inhibitors can be determined in a 30 μL, assay containing 20 mM HEPES, pH 7.5, 2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
US Patent